发明名称 TETRAHYDROPYRIDIN-4-YL INDOLES WITH A COMBINATION OF AFFINITY FOR DOPAMINE-D2 RECEPTORS AND SEROTONIN REUPTAKE SITES
摘要 The present invention relates to a group of novel tetrahydropyridin-4-yl indoles with a dual mode of action: serotonin reuptake inhibition and affinity for dopamine-D2 receptors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said tetrahydropyridin-4-yl indoles. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The invention relates to novel tetrahydropyridin-4-yl indoles of the formula (I) and tautomers, stereoisomers, prodrugs, N-oxides, pharmacologically acceptable salts, hydrates and solvates thereof, wherein:-R1 is hydrogen, halogen, alkyl (C1-3) or alkoxy(C1-3), CN or CF 3,-R2 is hydrogen or alkyl (C1-3), R 3 is hydrogen or alkyl (C1-3),-Z is hydrogen or alkyl (C1-3), alkoxy(C1-3) or alkylthio(C1-3),-A is hydrogen or alkyl (C1-3), or-A and Z together form a saturated or (partly) unsaturated 5-or 6-membered ring which may be substituted with halogen, alkyl (C1-3) or phenyl, in which ring Z represents carbon, sulfur of nitrogen.
申请公布号 KR20070091009(A) 申请公布日期 2007.09.06
申请号 KR20077015615 申请日期 2007.07.06
申请人 SOLVAY PHARMACEUTICALS B.V. 发明人 VAN HES ROELOF;SMID PIETER;KRUSE CORNELIS G.;TULP MARTINUS TH. M.
分类号 C07D401/14;A61K31/506;A61P25/00 主分类号 C07D401/14
代理机构 代理人
主权项
地址